Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Other Non-Current Liabilities (2020 - 2025)

Rapid Micro Biosystems' Other Non-Current Liabilities history spans 6 years, with the latest figure at $358000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities rose 23.88% year-over-year to $358000.0; the TTM value through Sep 2025 reached $358000.0, up 23.88%, while the annual FY2023 figure was $263000.0, 14.85% up from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $358000.0 at Rapid Micro Biosystems, up from $314000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $15.6 million in Q2 2021 and bottomed at $221000.0 in Q3 2022.
  • The 5-year median for Other Non-Current Liabilities is $297500.0 (2024), against an average of $2.1 million.
  • The largest annual shift saw Other Non-Current Liabilities soared 345.84% in 2021 before it plummeted 95.53% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.2 million in 2021, then tumbled by 81.07% to $229000.0 in 2022, then rose by 14.85% to $263000.0 in 2023, then rose by 9.89% to $289000.0 in 2024, then grew by 23.88% to $358000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Other Non-Current Liabilities are $358000.0 (Q3 2025), $314000.0 (Q2 2025), and $306000.0 (Q1 2025).